On Aug. 30, the U.S. Food and Drug Administration (FDA) approved Linzess (linaclotide) to treat chronic idiopathic constipation and to treat irritable bowel syndrome…
On Aug. 9, the U.S. Food and Drug Administration (FDA) approved Marqibo (vincristine sulfate liposome injection) to treat adults with Philadelphia chromosome negative (Ph-)…
On Aug. 22, the Institute of Medicine released “Accelerating the development of new drugs and diagnostics: Maximizing the impact of the Cures Acceleration Network—Workshop…
On June 8, the U.S. Food and Drug Administration (FDA) approved Perjeta (pertuzumab), a new anti-HER2 therapy, to treat patients with HER2-positive late-stage breast…
Researchers at MIT have developed a needle-free injection device to deliver drugs. The device offers greater control than previous devices for regulating delivery volume…
There is a saying that if you’ve experienced one influenza season, you’ve experienced one influenza season. Influenza is a highly unpredictable virus, and the…
On March 29, the U.S. Food and Drug Administration (FDA) announced that a two-day expert advisory panel meeting on metal-on-metal hip replacement systems will…
On Aug. 30, the U.S. Food and Drug Administration (FDA) approved Linzess (linaclotide) to treat chronic idiopathic constipation and to treat irritable…
On Aug. 9, the U.S. Food and Drug Administration (FDA) approved Marqibo (vincristine sulfate liposome injection) to treat adults with Philadelphia chromosome…
Researchers at MIT have developed a needle-free injection device to deliver drugs. The device offers greater control than previous devices for regulating…
There is a saying that if you’ve experienced one influenza season, you’ve experienced one influenza season. Influenza is a highly unpredictable virus,…